8 August 2015 - In 1994 Gordon Naylor, like hundreds of other CSL employees, received a $1,000 parcel of shares in the privatisation of Commonwealth Serum Laboratories. The $300 million float had been sold at $2.30 a piece. After the share price slumped to a low of 78c in its first year, CSL looked like a terrible investment.

Naylor sold his initial parcel when CSL hit 7 bucks in April 1997, feeling pretty happy that he had more than tripled his investment.

If the story of his investment ended there it could have caused some regret, given the biotechnology giant is now worth $47 billion and this week its share price pierced through the $100 mark.

Those initial employee share parcels would now be worth $122,700, or $180,580 if you include dividends too, according to Bloomberg.

For more details, go to: http://www.afr.com/business/health/biotechnology/csl-executive-gordon-naylor-on-how-to-create-advanced-manufacturing-success-20150806-gitkkg